ANTARES PHARMA INC's ticker is ATRS and the CUSIP is 036642106. A total of 84 filers reported holding ANTARES PHARMA INC in Q4 2013. The put-call ratio across all filers is 0.62 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $100,000 | -38.3% | 50,000 | 0.0% | 0.00% | – |
| Q3 2017 | $162,000 | +153.1% | 50,000 | +150.0% | 0.00% | – |
| Q2 2017 | $64,000 | +12.3% | 20,000 | 0.0% | 0.00% | – |
| Q1 2017 | $57,000 | +21.3% | 20,000 | 0.0% | 0.00% | – |
| Q4 2016 | $47,000 | +38.2% | 20,000 | 0.0% | 0.00% | – |
| Q3 2016 | $34,000 | +61.9% | 20,000 | 0.0% | 0.00% | – |
| Q2 2016 | $21,000 | +23.5% | 20,000 | 0.0% | 0.00% | – |
| Q1 2016 | $17,000 | -29.2% | 20,000 | 0.0% | 0.00% | – |
| Q4 2015 | $24,000 | -29.4% | 20,000 | 0.0% | 0.00% | – |
| Q3 2015 | $34,000 | -19.0% | 20,000 | 0.0% | 0.00% | – |
| Q2 2015 | $42,000 | -22.2% | 20,000 | 0.0% | 0.00% | – |
| Q1 2015 | $54,000 | +5.9% | 20,000 | 0.0% | 0.00% | – |
| Q4 2014 | $51,000 | +37.8% | 20,000 | 0.0% | 0.00% | – |
| Q3 2014 | $37,000 | -30.2% | 20,000 | 0.0% | 0.00% | – |
| Q2 2014 | $53,000 | -24.3% | 20,000 | 0.0% | 0.00% | – |
| Q1 2014 | $70,000 | -22.2% | 20,000 | 0.0% | 0.00% | – |
| Q4 2013 | $90,000 | +11.1% | 20,000 | 0.0% | 0.00% | – |
| Q3 2013 | $81,000 | -2.4% | 20,000 | 0.0% | 0.00% | – |
| Q2 2013 | $83,000 | – | 20,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sargent Investment Group, LLC | 3,096,355 | $8,422,000 | 5.18% |
| JW Asset Management, LLC | 1,920,524 | $5,224,000 | 3.85% |
| Healthcare Value Capital, LLC | 250,000 | $680,000 | 2.64% |
| ARMISTICE CAPITAL, LLC | 10,300,000 | $28,016,000 | 2.12% |
| Broadfin Capital, LLC | 3,444,147 | $9,368,000 | 1.23% |
| PERKINS CAPITAL MANAGEMENT INC | 409,000 | $1,112,000 | 0.86% |
| MYCIO WEALTH PARTNERS, LLC | 1,896,500 | $5,158,000 | 0.48% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 1,012,600 | $2,754,000 | 0.22% |
| FALCON POINT CAPITAL, LLC | 130,200 | $354,000 | 0.21% |
| Brown Advisory Securities, LLC | 275,000 | $781,000 | 0.15% |